Histological and molecular studies have revealed altered expression and distribution patterns of NKCC1 and KCC2 in the dysplastic neurons of patients with FCD exhibiting epilepsy (Aronica et al., 2007; Munakata et al., 2007; Sen et al., 2007). Here, SLC12A5 is linked to epilepsy.